StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.15−0.39 (-4.57%)

Close on Nov 17, 2026Market cap $284.29MP/E –Yield –

Earnings

Benitec Biopharma's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 11, 2027
Q2 FY2027 · estimated, before the open
Revenue, Q1 FY2027
–
EPS, Q1 FY2027
-$0.26
-$0.22 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Benitec Biopharma's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2027ended Dec 31, 2026Feb 11, 2027Expected––––
Q1 FY2027ended Sep 30, 2026Nov 13, 2026before the open––-$0.26Release
Q4 FY2026ended Jun 30, 2026Sep 14, 2026after the close–––Release
Q3 FY2026ended Mar 31, 2026May 14, 2026before the open––-$0.24Release
Q2 FY2026ended Dec 31, 2025Feb 12, 2026before the open––-$0.26Release
Q1 FY2026ended Sep 30, 2025Nov 14, 2025after the close––-$0.22Release
Q4 FY2025ended Jun 30, 2025Sep 22, 2025after the close–––Release
Q3 FY2025ended Mar 31, 2025May 14, 2025before the open––-$0.24Release
Q2 FY2025ended Dec 31, 2024Feb 14, 2025before the open$0–-$0.33Release
Q1 FY2025ended Sep 30, 2024Nov 14, 2024after the close$0–-$0.48Release
Q4 FY2024ended Jun 30, 2024Sep 26, 2024after the close–––Release
Q3 FY2024ended Mar 31, 2024May 13, 2024before the open$0-100.0%-$1.64Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Benitec Biopharma has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Benitec Biopharma puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Benitec Biopharma filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Update
  4. Results
  5. Results
  6. Results
  7. Results
  8. News
  9. Update
  10. Update
  11. Update
  12. Results
  13. Update
  14. Results
  15. News

See a number that looks wrong?